共 50 条
- [31] Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study HEADACHE, 2022, 62 (01): : 78 - 88
- [32] Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment HEADACHE, 2022, 62 (01): : 65 - 77
- [33] Safety and Tolerability of Galcanezumab in Patients With Chronic Cluster Headache With Up to 15 Months of Galcanezumab Treatment HEADACHE, 2020, 60 : 123 - 124
- [36] Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study The Journal of Headache and Pain, 24
- [37] Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache Drugs, 2020, 80 : 1379 - 1379